Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: Comparison of pooled data

Journal of the American College of Cardiology

Volumn 30, Issue 6, 1997, Pages 1451-1460

  Bax, Jeroen J ^a   Wijns, William ^b   Cornel, Jan H ^c   Visser, Frans C ^d   Boersma, Eric ^e   Fioretti, Paolo M ^f  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CARDIOVASCULAR CENTER   (Belgium)

^c Alkmaar and Dutch Network for Cardiovascular Research   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE; FLUORODEOXYGLUCOSE F 18; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; THALLIUM 201;

ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE REVASCULARIZATION; HEART SCINTISCANNING; HUMAN; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT OUTCOME;

CHRONIC DISEASE; CONFIDENCE INTERVALS; CORONARY DISEASE; DOBUTAMINE; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIAL REVASCULARIZATION; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0030720090     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00352-5     Document Type: Article

References (101)

1. Rahimtoola SH. The hibernating myocardium. Am Heart J 1989;117:211-21.
2. Bolli R. Myocardial "stunning" in man. Circulation 1992;86:1671-91.
3. Dilsizian V, Bonow RO. Current diagnostic techniques of assessing viability in patients with hibernating and stunned myocardium. Circulation 1993;87: 1-20.
4. Alderman EL, Fisher LD, Litwin P, et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation 1983;68: 785-95.
5. Pigott JD, Kouchoukos NT, Oberman A, Cutter GR. Late results of surgical and medical therapy for patients with coronary artery disease and depressed left ventricular function. J Am Coll Cardiol 1985;5:1036-45.
6. Mickleborough LL, Maruyama H, Takagi Y, et al. Results of revascularization in patients with severe left ventricular dysfunction. Circulation 1995;92 Suppl II:II-73-9.
7. Flameng W, Suy R, Schwarz F, et al. Ultrastructural correlates of left ventricular contraction abnormalities in patients with chronic ischemic heart disease: determinants of reversible segmental asynergy postrevascularization study. Am Heart J 1981;102:846-57.
8. Borgers M, Thone F, Wouters L, Ausma J, Shivalkar B, Flameng W. Structural correlates of regional myocardial dysfunction in patients with critical coronary artery stenosis: chronic hibernation? Cardiovasc Pathol 1993;2:237-45.
9. Depré C, Vanoverschelde JL-J, Melin JA, et al. Structural and metabolic correlates of the reversibility of chronic left ventricular ischemic dysfunction in humans. Am J Physiol 1995;268:H1265-75.
10. Maes A, Flameng W, Nuyts J, et al. Histological alterations in chronically hypoperfused myocardium: correlation with PET findings. Circulation 1994;90:735-45.
11. Vanoverschelde JLJ, Wijns W, Depré C, et al. Mechanisms of chronic regional postischemic dysfunction in humans: new insights from the study of noninfarcted collateral-dependent myocardium. Circulation 1993;87:1513-23.
12. Vanoverschelde JLJ, Wijns W, Borgers M, et al. Pathophysiology of chronic myocardial hibernation: from bench to bedside. Circulation 1997;95:1961-71.
13. 18F-labeled fluorodeoxyglucose and N-13 ammonia. Circulation 1981;64:766-78.
14. Schwaiger M, Hicks R. The clinical role of metabolic imaging of the heart by positron emission tomography. J Nucl Med 1991;32:565-78.
15. Schelbert HR. Positron emission tomography for the assessment of myocardial viability. Circulation 1991;84 Suppl I:I-122-31.
16. Marwick TH, MacIntyre WJ, Lafont A, Nemec JJ, Salcedo EE. Metabolic responses of hibernating and infarcted myocardium to revascularization. Circulation 1992;85:1347-53.
17. Gerber BL, Vanoverschelde J-LJ, Bol A, et al. Myocardial blood flow, glucose uptake and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction: implications for the pathophysiology of chronic hibernation. Circulation 1996;94:651-9.
18. Tamaki N, Yonekura Y, Yamashita K, et al. PET using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting. Am J Cardiol 1989;64:860-5.
19. Gropler RJ, Geltman EM, Sampathkumaran K, et al. Comparison of carbon-11 acetate with fluorine-18 fluorodeoxyglucose for delineating viable myocardium by positron emission tomography. J Am Coll Cardiol 1993;22:1587-97.
20. Maes AF, Borgers M, Flameng W, et al. Assessment of myocardial viability in chronic coronary artery disease using technetium-99m sestamibi SPECT: correlation with histologic and positron mission tomographic studies and functional follow-up. J Am Coll Cardiol 1997;29:62-8.
21. Tamaki N, Kawamoto M, Tadamura E, et al. Prediction of reversible ischemia after revascularization: perfusion and metabolic studies with positron emission tomography. Circulation 1995;91:1697-705.
22. Knuuti MJ, Saraste M, Nuutila P, et al. Myocardial viability: fluorine-18-deoxyglucose positron emission tomography in prediction of wall motion recovery after revascularization. Am Heart J 1994;127:785-96.
23. Baer FM, Voth E, Deutsch HJ, et al. Predictive value of low dose dobutamine transesophageal echocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography for recovery of regional left ventricular function after successful revascularization. J Am Coll Cardiol 1996;28:60-9.
24. Lucignani G, Paolini G, Landoni C, et al. Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutylisonitrile SPECT and fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography in patients with coronary artery disease. Eur J Nucl Med 1992;19:874-81.
25. Carrel T, Jenni R, Haubold-Reuter S, Von Schulthess G, Pasic M, Turina M. Improvement of severely reduced left ventricular function after surgical revascularization in patients with preoperative myocardial infarction. Eur J Cardiothorac Surg 1992;6:479-84.
26. Tillisch J, Brunken R, Marshall R, et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 1986;314: 884-8.
27. Tamaki N, Ohtani H, Yamashita K, et al. Metabolic activity in the areas of new fill-in after thallium-201 reinjection: comparison with positron emission tomography using fluorine-18-deoxyglucose. J Nucl Med 1991;32: 673-8.
28. Vom Dahl J, Eitzman DT, Al-Aouar ZR, et al. Relation of regional function, perfusion and metabolism in patients with advanced coronary artery disease undergoing surgical revascularization. Circulation 1994;90: 2356-66.
29. Maes A, Flameng W, Borgers M, et al. Regional myocardial blood flow, glucose utilization and contractile function before and after revascularization and ultrastructural findings in patients with chronic coronary artery disease. Eur J Nucl Med 1995;22:1299-305.
30. Grandin C, Wijns W, Melin JA, et al. Delineation of myocardial viability with PET. J Nucl Med 1995;36:1543-52.
31. Dreyfus GD, Duboc D, Blasco A, et al. Myocardial viability assessment in ischemic cardiomyopathy: Benefits of coronary revascularization. Ann Thorac Surg 1994;57:1402-8.
32. Vom Dahl J, Altehoefer C, Sheehan FH, et al. Recovery of regional left ventricular dysfunction after coronary revascularization: impact of myocardial viability assessed by nuclear imaging and vessel patency at follow-up angiography. J Am Coll Cardiol 1996;28:948-58.
33. Sandler MP, Videlefsky S, Delbeke D, et al. Evaluation of myocardial ischemia using a rest metabolism/stress perfusion protocol with fluorine-18 deoxyglucose/technetium-99m MIBI and dual-isotope simultaneous-acquisition single-photon emission computed tomography. J Am Coll Cardiol 1995;26:870-88.
34. 18-fluorodeoxyglucose/thallium-201 single photon emission computed tomography, thallium-201 stress-reinjection single photon emission computed tomography and dobutamine echocardiography. J Am Coll Cardiol 1996; 28:558-64.
35. Dilsizian V, Rocco TP, Freedman NMT, Leon MB, Bonow RO. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 1990;323:141-6.
36. Tamaki N, Ohtani H, Yonekura Y, et al. Significance of fill-in after thallium-201 reinjection following delayed imaging: comparison with regional wall motion and angiographic findings. J Nucl Med 1990;31:1617-23.
37. Ohtani H, Tamaki N, Yonekura Y, et al. Value of thallium-201 reinjection after delayed SPECT imaging for predicting reversible ischemia after coronary artery bypass grafting. Am J Cardiol 1990;66:394-9.
38. Bonow RO, Dilsizian V, Cuocolo A, Bacharach SL. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction: comparison of thallium scintigraphy with reinjection and PET imaging with 18-F-fluorodeoxyglucose. Circulation 1991;83: 26-37.
39. Dilsizian V, Freedman NMT, Bacharach SL, Perrone-Filardi P, Bonow RO. Regional Tl uptake in irreversible defects: magnitude of change in Tl activity after reinjection distinguishes viable from nonviable myocardium. Circulation 1992;85:627-34.
40. Arnese M, Cornel JH, Salustri A, et al. Prediction of improvement of regional left ventricular function after surgical revascularization: a comparison of low-dose dobutamine echocardiography with 201-Tl SPECT. Circulation 1995;91:2748-52.
41. Haque T, Furukawa T, Takahashi M, Kinoshita M. Identification of hibernating myocardium by dobutamine stress echocardiography: comparison with thallium-201 reinjection imaging. Am Heart J 1995;130:553-63.
42. Vanoverschelde J-LJ, D'Hondt A-M, Marwick T, et al. Head-to-head comparison of exercise-redistribution-reinjection thallium single-photon emission computed tomography and low dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischemic dysfunction. J Am Coll Cardiol 1996;28:432-42.
43. Dilsizian V, Perrone-Filardi P, Arrighi JA, et al. Concordance and discordance between stress-redistribution-reinjection and rest-redistribution thallium imaging for assessing viable myocardium: comparison with metabolic activity by positron emission tomography. Circulation 1993;88:941-52.
44. Galassi AR, Centamore G, Fiscella A, et al. Comparison of rest-redistribution thallium-201 imaging and reinjection after stress-redistribution for the assessment of myocardial viability in patients with left ventricular dysfunction secondary to coronary artery disease. Am J Cardiol 1995;75:436-42.
45. Mori T, Minamiji K, Kurogane H, Ogawa K, Yoshida Y. Rest-injected thallium-201 imaging for assessing viability of severe asynergic regions. J Nucl Med 1991;32:1718-24.
46. Marzullo P, Parodi O, Reisenhofer B, et al. Value of rest thallium-201/ technetium-99m sestamibi and dobutamine echocardiography for detecting myocardial viability. Am J Cardiol 1993;71:166-72.
47. 99Tc-sestamibi. Circulation 1994;89:2552-61.
48. Ragosta M, Beller GA, Watson DD, Kaul S, Gimple LW. Quantitative planar rest-redistribution Tl-201 imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary artery bypass surgery in patients with severely depressed left ventricular function. Circulation 1993;87:1630-41.
49. Alfieri O, La Canna G, Giubinni R, Pardini A, Zogno M, Fucci C. Recovery of myocardial function. Eur J Cardiothorac Surg 1993;7:325-30.
50. Charney R, Schwinger ME, Chun J, et al. Dobutamine echocardiography and resting-redistribution thallium-201 scintigraphy predicts recovery of hibernating myocardium after coronary revascularization. Am Heart J 1994;128:864-9.
51. 201Tl tomography versus dobutamine echocardiography. Circulation 1996;94:2712-9.
52. 201Tl uptake and comparative prediction of recovery of function. Circulation 1997;95:626-35.
53. Iskandrian AS, Hakki A, Kane SA, et al. Rest and redistribution thallium-201 myocardial scintigraphy to predict improvement in left ventricular function after coronary arterial bypass grafting. Am J Cardiol 1983;51: 1312-6.
54. Berman DS, Kiat H, Van Train K, Garcia E, Friedman J, Maddahi J. Technetium 99m sestamibi in the assessment of chronic coronary artery disease. Semin Nucl Med 1991;21:190-212.
55. Beanlands RSB, Dawood F, Wen WH, et al. Are the kinetics of technetium 99m-methoxy isobutyl isonitrile affected by cell metabolism and viability? Circulation 1990;82:1802-14.
56. Piwnica-Worms D, Kronauge J, Chiu M. Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium(I) in cultured chick myocardial cells: mitochondrial and plasma membrane potential dependence. Circulation 1990;82:1826-38.
57. Freeman I, Grunwald AM, Hoory S, Bodenheimer MM. Effect of coronary occlusion and myocardial viability on myocardial activity of technetium-99m-sestamibi. J Nucl Med 1991;32:292-8.
58. Cuocolo A, Pace L, Ricciardelli B, Chiariello M, Trimarco B, Salvatore M. Identification of viable myocardium in patients with chronic coronary artery disease: comparison of thallium-201 scintigraphy with reinjection and technetium-99m-methoxyisobutyl isonitrile. J Nucl Med 1992;33:505-11.
59. 18F]fluorodeoxyglucose. Circulation 1994;89:578-87.
60. Dondi M, Tartagni F, Fallani F, et al. A comparison of rest sestamibi and rest-redistribution single photon emission tomography: possible implications for myocardial viability detection in infarcted patients. Eur J Nucl Med 1993;20:26-31.
61. Maurea S, Cuocolo A, Pace L, et al. Rest-injected thallium-201 redistribution and resting technetium-99m methoxyisobutylisonitrile uptake in coronary artery disease: relation to the severity of coronary artery stenosis. Eur J Nucl Med 1993;20:502-10.
62. Cuocolo A, Maurea S, Pace L, et al. Resting technetium-99m methoxyisobutylisonitrile cardiac imaging in chronic coronary artery disease: comparison with rest-redistribution thallium-201 scintigraphy. Eur J Nucl Med 1993;20:1186-92.
63. Rossetti C, Landoni C, Lucignani G, et al. Assessment of myocardial perfusion and viability with technetium-99m methoxyisobutylisonitrile and thallium-201 rest redistribution in chronic coronary artery disease. Eur J Nucl Med 1995;22:1306-12.
64. Kauffman GJ, Boyne TS, Watson DD, Smith WH, Beller GA. Comparison of rest thallium-201 imaging and rest technetium-99m sestamibi for assessment of myocardial viability in patients with coronary artery disease and severe left ventricular dysfunction. J Am Coll Cardiol 1996;27:1592-7.
65. Altehoefer C, Kaiser HJ, Doerr R, et al. Fluorine-18 deoxyglucose PET for assessment of viable myocardium in perfusion defects in 99TC-MIBI SPET: a comparative study in patients with coronary artery disease. Eur J Nucl Med 1992;19:334-42.
66. Altehoefer C, Vom Dahl J, Biedermann M, et al. Significance of defect severity in technetium-99m-MIBI SPECT at rest to assess myocardial viability: comparison with fluorine-18-FDG PET. J Nucl Med 1994;35:569-74.
67. Sawada S, Allman KC, Muzik O, et al. Positron emission tomography detects evidence of viability in rest technetium-99m sestamibi defects. J Am Coll Cardiol 1994;23:92-8.
68. Soufer R, Dey HM, Ng CK, Zaret BL. Comparison of sestamibi single-photon emission computed tomography with positron emission tomography for estimating left ventricular myocardial viability. Am J Cardiol 1995;75: 1214-9.
69. 18FDG uptake in chronic coronary artery disease. Nucl Med Commun 1995;16:548-57.
70. Marzullo P, Sambucetti G, Parodi O, et al. Regional concordance and discordance between rest thallium 201 and sestamibi imaging for assessing tissue viability: comparison with postrevascularization functional recovery. J Nucl Cardiol 1995;2:309-16.
71. Gonzalez P, Massardo T, Munoz A, et al. Is the addition of ECG gating to technetium-99m sestamibi SPET of value in the assessment of myocardial viability? Eur J Nucl Med 1996;23:1315-22.
72. Marzullo P, Sambuceti G, Parodi O. The role of sestamibi scintigraphy in the radioisotopic assessment of myocardial viability. J Nucl Med 1992;33: 1925-30.
73. Maublant JC, Citron B, Lipiecki J, et al. Rest technetium 99m-sestamibi in hibernating myocardium. Am Heart J 1995;129:306-14.
74. Maurea S, Cuocolo A, Soricelli A, et al. Enhanced detection of viable myocardium by technetium-99m-MIBI imaging after nitrate administration in chronic coronary artery disease. J Nucl Med 1995;36:1945-52.
75. Bisi G, Sciagrà R, Santoro GM, Fazzini PF. Rest technetium-99m sestamibi tomography in combination with short-term administration of nitrates: feasibility and reliability for prediction of postrevascularization outcome of asynergic territories. J Am Coll Cardiol 1994;24:1282-9.
76. Bisi G, Sciagrà R, Santoro GM, Rossi V, Fazzini PF. Technetium-99m-sestamibi imaging with nitrate infusion to detect viable hibernating myocardium and predict postrevascularization recovery. J Nucl Med 1995;36: 1994-2000.
77. Nicolai E, Cuocolo A, Pace L, et al. Assessment of systolic wall thickening using technetium-99m methoxyisobutylisonitrile in patients with coronary artery disease: relation to thallium-201 scintigraphy with reinjection. Eur J Nucl Med 1995;22:1017-22.
78. Cigarroa CG, deFilippi CR, Brickner ME, Alvarez LG, Wait MA, Grayburn PA. Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization. Circulation 1993;88:430-6.
79. Baer FM, Voth E, Deutsch HJ, Schneider CA, Schicha H, Sechtem U. Assessment of viable myocardium by dobutamine transesophageal echocardiography and comparison with fluorine-18 fluorodeoxyglucose PET. J Am Coll Cardiol 1994;24:343-53.
80. Panza JA, Dilsizian V, Laurienzo JM, Curiel RV, Katsiyiannis PT. Relation between thallium uptake and contractile response to dobutamine: implications regarding myocardial viability in patients with chronic coronary artery disease and left ventricular dysfunction. Circulation 1995;91:990-8.
81. Vanoverschelde J-LJ, Gerber BL, D'Hondt A-M, et al. Preoperative selection of patients with severely impaired left ventricular function for coronary revascularization: role of low-dose dobutamine echocardiography and exercise-redistribution-reinjection thallium SPECT. Circulation 1995;92 Suppl II:II-37-44.
82. Afridi I, Kleiman NS, Raizner AE, Zoghbi WA. Dobutamine echocardiography in myocardial hibernation: optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation 1995;91:663-70.
83. Senior R, Glenville B, Basu S, et al. Dobutamine echocardiography and thallium-201 imaging predict functional improvement after revascularization in severe ischaemic left ventricular dysfunction. Br Heart J 1995;74: 358-64.
84. Perrone-Filardi P, Pace L, Prastaro M, et al. Dobutamine echocardiography predicts improvement of hypoperfused dysfunctional myocardium after revascularization in patients with coronary artery disease. Circulation 1995;91:2556-65.
85. La Canna G, Alfieri O, Giubbini R, Gargano M, Ferrari R, Visoli O. Echocardiography during infusion of dobutamine for identification of reversible dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol 1994;23:617-26.
86. DeFilippi CR, Willett DWL, Irani WN, Eichhorn EJ, Velasco CE, Grayburn PA. Comparison of myocardial contrast echocardiography and low-dose dobutamine stress echocardiography in predicting recovery of left ventricular function after coronary revascularization in chronic ischemic heart disease. Circulation 1995;92:2863-8.
87. Meluzin J, Cigarroa CG, Brickner ME, et al. Dobutamine echocardiography in predicting improvement in global left ventricular systolic function after coronary bypass or angioplasty in patients with healed myocardial infarcts. Am J Cardiol 1995;76:877-80.
88. Picano E, Ostojic M, Varga A, et al. Combined low dose dipyridamoledobutamine stress echocardiography to identify myocardial viability. J Am Coll Cardiol 1996;27:1422-8.
89. Panza JA, Laurienzo JM, Curiel RV, Quyyumi AA, Cannon RO III. Transesophageal dobutamine stress echocardiography for evaluation of patients with coronary artery disease. J Am Coll Cardiol 1994;24:1260-7.
90. Voci P, Bilotta F, Caretta Q, Mercanti C, Marino B. Low-dose dobutamine echocardiography predicts the early response of dysfunctioning myocardial segments to coronary artery bypass grafting. Am Heart J 1995;129:521-6.
91. Irwig L, Tosteson ANA, Gatsonis C, et al. Guidelines for meta-analyses evaluating diagnostic tests. Ann Intern Med 1994;120:667-76.
92. 201Thallium SPECT and positron emission tomography: which test for the prediction of myocardial viability? [abstract]. Circulation 1994;90 Suppl I:I-314.
93. Vanoverschelde J-L, Melin JA, Depré C, Borgers M, Dion R, Wijns W. Time-course of functional recovery of hibernating myocardium after coronary revascularization [abstract]. Circulation 1994;90 Suppl I:I-378.
94. Hoffmann R, Lethen H, Marwick T, et al. Analysis of interinstitutional observer agreement in interpretation of dobutamine stress echocardiograms. J Am Coll Cardiol 1996;27:330-6.
95. Feigenbaum H. Quality control of stress echocardiography. Heart 1997;77: 97-8.
96. Eitzman D, Al-Aouar ZR, Kanter HL, et al. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol 1992;20:559-65.
97. Di Carli M, Davidson M, Little R, et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994;73:527-33.
98. Lee KS, Marwick TH, Cook SA, et al. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction: relative efficacy of medical therapy and revascularization. Circulation 1994;90:2687-94.
99. Kaul S. There may be more to myocardial viability than meets the eye! [editorial]. Circulation 1995;92:2790-3.
100. Marwick TH, Nemec JJ, Lafont A, Salcedo EE, MacIntyre WJ. Prediction by postexercise fluoro-18 deoxyglucose positron emission tomography of improvement in exercise capacity after revascularization. Am J Cardiol 1992;69:854-9.
101. Di Carli MF, Asgarzadie F, Schelbert HR, et al. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation 1995;92:3436-44.